Last --
Change Today 0.00 / 0.00%
Volume 0.0
524516 On Other Exchanges
Symbol
Exchange
524516 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

bacil pharma ltd (524516) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for BACIL PHARMA LTD (524516)

Related News

No related news articles were found.

bacil pharma ltd (524516) Related Businessweek News

No Related Businessweek News Found

bacil pharma ltd (524516) Details

Bacil Pharma Limited engages in trading agro commodities in India. It sells guar dal and guar split broken products. The company was incorporated in 1987 and is based in Mumbai, India.

Founded in 1987

bacil pharma ltd (524516) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

bacil pharma ltd (524516) Key Developments

Bacil Pharma Ltd Announces Board Appointments

Bacil Pharma Ltd. announced that it appointed Mr. Shirish Suryakant Shetye & Mr. Lalit Jain as Non-Executive/Independent Directors, at its board meeting held on February 14, 2014.

Bacil Pharma Ltd Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended December 31, 2013

Bacil Pharma Ltd. reported unaudited earnings results for the third quarter and nine months ended December 31, 2013. For the quarter, the company has posted loss from operations before other income, interest and exceptional items was INR 0.225 million against INR 0.438 million a year ago. Loss from ordinary activities before tax was INR 0.135 million against INR 0.393 million a year ago. Net loss was INR 0.135 million against INR 0.393 million a year ago. For the nine months, the company has posted loss from operations before other income, interest and exceptional items was INR 0.684 million against profit from operations before other income, interest and exceptional items INR 0.356 million a year ago. Loss from ordinary activities before tax was INR 0.276 million against profit from ordinary activities before tax was INR 0.401 million a year ago. Net loss was INR 0.276 million against net profit of INR 0.351 million a year ago.

Bacil Pharma Ltd to Report Q3, 2014 Results on Feb 14, 2014

Bacil Pharma Ltd announced that they will report Q3, 2014 results on Feb 14, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BAP:IN 1.41 INR 0.00

524516 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 524516.
View Industry Companies
 

Industry Analysis

524516

Industry Average

Valuation 524516 Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.4x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BACIL PHARMA LTD, please visit www.bacilpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.